ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 35 filers reported holding ONCOCYTE CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $39,000 | -48.0% | 25,949 | -25.0% | 0.00% | – |
| Q4 2021 | $75,000 | -35.3% | 34,606 | +6.4% | 0.00% | – |
| Q3 2021 | $116,000 | -79.4% | 32,513 | -66.8% | 0.00% | -100.0% |
| Q2 2021 | $562,000 | +0.7% | 97,877 | -9.0% | 0.00% | 0.0% |
| Q1 2021 | $558,000 | +144.7% | 107,507 | +12.9% | 0.00% | – |
| Q4 2020 | $228,000 | +72.7% | 95,193 | 0.0% | 0.00% | – |
| Q3 2020 | $132,000 | +5.6% | 95,193 | +45.9% | 0.00% | – |
| Q2 2020 | $125,000 | +52.4% | 65,227 | +94.8% | 0.00% | – |
| Q1 2020 | $82,000 | +10.8% | 33,478 | +1.2% | 0.00% | – |
| Q4 2019 | $74,000 | +7.2% | 33,095 | 0.0% | 0.00% | – |
| Q3 2019 | $69,000 | -15.9% | 33,095 | 0.0% | 0.00% | – |
| Q2 2019 | $82,000 | +530.8% | 33,095 | +417.1% | 0.00% | – |
| Q1 2018 | $13,000 | -56.7% | 6,400 | 0.0% | 0.00% | – |
| Q4 2017 | $30,000 | -37.5% | 6,400 | 0.0% | 0.00% | – |
| Q3 2017 | $48,000 | +45.5% | 6,400 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | +17.9% | 6,400 | +6.6% | 0.00% | – |
| Q1 2016 | $28,000 | – | 6,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,596,680 | $27,155,000 | 4.50% |
| Family Management Corp | 20,550 | $155,000 | 0.11% |
| Artal Group S.A. | 150,000 | $1,133,000 | 0.02% |
| Destination Wealth Management | 29,656 | $224,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 145,000 | $1,095,000 | 0.01% |
| Carroll Financial Associates, Inc. | 850 | $5,000 | 0.00% |
| Advisor Group, Inc. | 112 | $1,000 | 0.00% |
| FIFTH THIRD BANCORP | 210 | $2,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 10 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,413 | $18,000 | 0.00% |